The Mentors

Jeremy How

Email | LinkedIn

Vice President Marketplace Strategy

Company: B. Braun, Medical, Harrison Greenleaf Consulting, LLC, Avantor Performance Materials, inc., Air Products and Chemicals

After 20+ years at Air Products and Chemicals and 3+ years at Avantor Performance Materials, Jeremy started his own consulting company where he provided commercial services to his clients. One of his clients was B. Braun Medical which ultimately led to his current full time position as Vice President of Marketplace Strategy. Some of the responsibilities of his position include: Evaluate trends and developments associated with Population Health, Accountable Care Organizations, and the Affordable Care Act to position B. Braun favorably within its GPO, Distribution and Customer (IDN) opportunities. Understand how political change/CMS affects current population health initiatives and potential impact on B. Braun market place strategy. Develop relationships with key customer and industry population health experts to identify opportunities for innovation. Develop the new commercial model and how we will contract with our customers in the future - customer segmentation, contracting strategy, commercial risk, etc. Evaluate and implement innovative business models - Amazon Business, etc. With experiences at a publicly traded company (Air Products), Private Equity owned company (Avantor), independent consultancy and now a family owned $7B+ global company (B Braun Medical), Jeremy has the real world experiences to assist you with developing your business plan for your new product.


Sectors:

  • Biotechnology
  • Devices
  • Digital Health
  • Pharmaceuticals








Justin Alexander

Email | LinkedIn

Industry Senior Principal

Company: Accenture, Purdue Pharma, IBM, GSK

Justin Alexander is an energetic business and technology leader with over 20 years of biopharmaceutical information technology leadership and global consulting experience. He has extensive business development, account management, and program/project management with a focus on process improvement, change management, and cloud-based information technology. He is highly creative and focused with successful experience selling and delivering large-scale global projects through US and international-based delivery centers. Justin can guide you in solving healthcare problems in Pharma, biotech, and medical devices and assist you with product strategy, pricing, financing, and market analysis.


Sectors:

  • Biotechnology
  • Devices
  • Digital Health
  • Operations
  • Pharmaceuticals

Seth Freedman

Email | LinkedIn

Director of Corporate Development and Investments

Company: Independence Health Group

Justin is an energetic business and technology leader with over 20 years of biopharmaceutical information technology leadership and global consulting experience. He has extensive business development, account management, and program/project management with a focus on process improvement, change management, and cloud-based information technology. He is highly creative and focused with successful experience selling and delivering large-scale global projects through US and international-based delivery centers. Justin can guide you in solving healthcare problems in Pharma, biotech, and medical devices and assist you with product strategy, pricing, financing, and market analysis.

Sectors:

  • Devices
  • Digital Health
  • Insurance
  • Public Health
  • Healthcare Data/informatics
  • Health systems

Charlie Coltman

Email | LinkedIn

Founder/CEO of CancerLife

Company: Independence Health Group

After Charlie lost his best friend to pancreatic cancer in 2013, he set out to create a single mobile based support platform for cancer families who had trouble communicating and staying in touch. With over 20 years in Enterprise Software Sales experience. Charlie has worked at some of the largest software companies in the world such as SAP and Ariba as well at some of the most innovative SaaS companies in the technology sector. He consistently sold the largest revenue license deals in those firms. He spends his free time outside so long as the temperature is above freezing: golfing, biking, running and hiking.


Yilmaz Kaymak

Email | LinkedIn

Senior Manager, Client & Market

Company: Accenture

Yilmaz Kaymak is a senior manager with Accenture, a global consulting and professional services company that provides services in strategy, consulting, digital solutions, technology, and operations to more than three quarters of the Fortune Global 500 in more than 120 countries. With expertise across the health care industry, Accenture partners with most of the leading health care companies in the United States. Kaymak has earned two graduate degrees-in finance and in innovation and technology management-from the Wharton School of the University of Pennsylvania. Before joining Accenture, Kaymak was helping to develop a proprietary therapy called tumor-threating fields with Novocure, a commercial-stage oncology company. Prior to this, Kaymak assisted with the integration of Wyeth into Pfizer Pharmaceuticals.


Sectors:

  • Biotechnology
  • Devices
  • Digital Health
  • Pharmaceuticals

James M. Wilson, MD, PhD

Email | Website

Professor of Medicine and Pediatrics | Rose H. Weiss Professor and Director, Orphan Disease Center | Director, Gene Therapy Program

Company: PSOM, UPenn | Advisor and Founder, Scout Bio | Advisor and Founder, Passage Bio

James M. Wilson, MD, PhD, is a Professor in the Perelman School of Medicine at the University of Pennsylvania where he has led an effort to develop the field of gene therapy. His research career spanning over 40 years has focused on rare diseases and ways to treat them by gene therapy. The Wilson lab identified a new type of vector based on novel isolates of adenoassociated viruses which have become best in class for gene therapy being used by over 28 companies. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.



Sectors:

  • Biotechnology